Recruiting NA Osteoarthritis Wrist

New treatment option for Osteoarthritis Wrist

Official title Norwegian Distal Ulna Resection - Replacement Study

ClinicalTrials.gov ID: NCT04074863

What this study is testing

What it's testing
Osteoarthritis of the joint between the forearm bones at the wrist (distal radioulnar joint, DRUJ) is a common sequel of fracture and ligament injuries or degenerative disease of the wrist. Intact DRUJ is important for normal load transfer from the hand to the forearm.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 30 to 75

You may be able to join if

  • painful osteoarthritis distal radioulnar joint
  • stable DRUJ

You likely can't join if

  • activ inflammatory disease with significant destruction of the joint
  • "low demand" persons
  • significant instability i DRUJ
  • active infections, poor soft tissue conditions
  • accidental wound on the operated hand
  • general contraindications for surgery

The study team makes the final eligibility decision.

Where it's taking place

  • Lillehammer, Oppland, Norway
  • Bergen, Norway
  • Oslo, Norway
  • Tromsø, Norway
  • Trondheim, Norway
  • Moss, Østfold fylke, Norway

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 30 years to 75 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Lillehammer, Oppland, Norway; Bergen, Norway; Oslo, Norway; Tromsø, Norway; Trondheim, Norway; Moss, Østfold fylke, Norway. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.